Sanofi
SNY
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, otā¦ read more
Healthcare
Drug ManufacturersāGeneral
23 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$42.86
Price+0.85%
$0.36
1Y
Price
Market Cap
$103.221b
Large
Price/Earnings 3y Avg5y Avg
18.4x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in EUR.+24.2%
EBITDA Margin+14.4%
Net Profit Margin+14.1%
Free Cash Flow Margin+24.2%
EBITDA Margin+14.4%
Net Profit Margin+14.1%
Free Cash Flow MarginRevenue
$47.354b
+1.4%
1y CAGR+4.4%
3y CAGR+4.0%
5y CAGREarnings
$7.555b
-3.3%
1y CAGR+13.4%
3y CAGR+1.2%
5y CAGREPS
$1.95
-39.1%
1y CAGR+3.0%
3y CAGR-5.9%
5y CAGRBook Value
$73.143b
$128.024b
Assets$54.881b
Liabilities$20.021b
DebtDebt to Assets
15.6%
1.6x
Debt to EBITDAFree Cash Flow
$8.275b
-18.4%
1y CAGR+7.4%
3y CAGR+6.5%
5y CAGRNo items found.
Press Releases
Statements and updates from the company